Chemours Co Stock
€15.29
Your prediction
Chemours Co Stock
Pros and Cons of Chemours Co in the next few years
Pros
Cons
Performance of Chemours Co vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Chemours Co | 7.710% | -11.771% | 14.704% | -4.616% | 50.196% | -52.226% | -25.632% |
| Axalta Coating Systems Ltd. | -0.680% | 2.098% | 2.817% | -14.620% | 5.797% | 8.148% | 26.957% |
| Quaker Chemical Corp. | -0.680% | -2.667% | 8.148% | 8.148% | 20.661% | - | - |
| Newmarket Corp. | -0.980% | 1.815% | -6.481% | -3.810% | -15.126% | 59.810% | 54.908% |
Comments
News
Why Chemours Plunged Today
Shares of European chemicals company Chemours (NYSE: CC) fell 16.8% on Friday, as of 2:46 p.m. EDT.
The chemicals giant reported lackluster earnings today and also provided guidance that merely met
This Chemicals Stock Is Down 32% but Just Became a Top 5 Holding After One Fund's $13 Million Bet
New York City-based Alta Fundamental Advisers initiated a new position in The Chemours Company (NYSE:CC), acquiring 800,000 shares valued at an estimated $12.67 million, according to a November 13
Luminus Trims Its Hefty Chemours Position
Luminus Management LLC reduced its stake in The Chemours Company (NYSE:CC) during Q3 2025, selling shares worth an estimated $4.30 million, based on the average quarterly price, according to an SEC


